Therese Killeen to Middle Aged
This is a "connection" page, showing publications Therese Killeen has written about Middle Aged.
Connection Strength
0.371
-
Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study. J Sex Marital Ther. 2014; 40(6):552-60.
Score: 0.032
-
Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat. 2008 Oct; 35(3):304-11.
Score: 0.021
-
Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7.
Score: 0.017
-
The effect of auricular acupuncture on psychophysiological measures of cocaine craving. Issues Ment Health Nurs. 2002 Jul-Aug; 23(5):445-59.
Score: 0.014
-
Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 04; 34(2):454-466.
Score: 0.013
-
Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychol Assess. 2020 Nov; 32(11):1015-1027.
Score: 0.013
-
N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
Score: 0.012
-
Estimation of equable scale scores and treatment outcomes from patient- and clinician-reported PTSD measures using item response theory calibration. Psychol Assess. 2020 Apr; 32(4):321-335.
Score: 0.012
-
Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behav Cogn Psychother. 2020 Jan; 48(1):38-53.
Score: 0.012
-
Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 06 01; 199:70-75.
Score: 0.012
-
Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 03; 90:35-39.
Score: 0.011
-
Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials. Drug Alcohol Depend. 2018 09 01; 190:255-262.
Score: 0.011
-
Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. Contemp Clin Trials. 2017 10; 61:108-114.
Score: 0.010
-
The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218.
Score: 0.010
-
Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161.
Score: 0.010
-
Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35.
Score: 0.010
-
Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length. J Trauma Stress. 2017 04; 30(2):166-172.
Score: 0.010
-
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women. J Addict Med. 2017 Mar/Apr; 11(2):119-125.
Score: 0.010
-
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
Score: 0.010
-
Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide. Contemp Clin Trials. 2016 Mar; 47:325-33.
Score: 0.009
-
Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75.
Score: 0.009
-
To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD. Am J Addict. 2015 Oct; 24(7):578-81.
Score: 0.009
-
Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23.
Score: 0.009
-
Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. Am J Addict. 2015 Jun; 24(4):336-40.
Score: 0.009
-
Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res. 2014 Mar; 50:26-35.
Score: 0.008
-
Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan; 44(1):103-14.
Score: 0.007
-
Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Subst Use Misuse. 2012 May; 47(6):695-707.
Score: 0.007
-
Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64.
Score: 0.007
-
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
Score: 0.006
-
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug; 77(4):607-19.
Score: 0.006
-
Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008 Sep; 59(9):1056-9.
Score: 0.006
-
Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008 Apr; 69(4):520-5.
Score: 0.005
-
Long-term outcomes following decompressive craniectomy for severe head injury. Acta Neurochir Suppl. 2008; 102:29-31.
Score: 0.005
-
Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol. 2007 Oct; 75(5):805-11.
Score: 0.005
-
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
Score: 0.004
-
Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89.
Score: 0.004
-
Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse. 1996 Feb; 22(1):75-93.
Score: 0.002
-
Depression in alcoholic schizophrenic patients. Am J Psychiatry. 1993 Aug; 150(8):1255-6.
Score: 0.002